Tip Your Editors:
tips@consumerist.com
Editor:
Ben Popken | Email | AIM
Senior Editor:
Meghann Marco
Email | AIM
Associate Editor:
Chris Walters | Email |AIM
Associate Editor:
Alex Chasick | Email
Associate Editor:
Jay Slatkin | Email
Weekend Editor:
Carey Greenberg-Berger | Email | AIM
Interns:
Rachel Mercer | Email
Alex Jarvis | Email
Comments Moderator: Email
Click on the star next to each commenter to see their Connectedness Index.
A new meta-analysis showed that popular anemia drugs Aranesp and Procrit increase the risk of death in cancer patients by 10 percent, a statistically significant number. [NYT]
6:16 PM on Tue Feb 26 2008
By Ben Popken
487 views
2 comments
Consumerist
Comments
There's a side effect you don't usually hear listed in pharmaceutical commercials.
Back to the drawing board, I guess. I wonder, as a patient, whether I'd come down on the "benefits are worth the risk" side of the equation, or the "cure is worse than the disease" side.
I'd just as soon never find out.
@apotheosis: I guess that depends on why you have anemia, how severe it is, and what your existing risk for getting cancer is.
Start a discussion:
Login with your username and password below. Or comment on this post via email.
Forgot your username or password? New User?